Predict your next investment

HEALTHCARE | Drug Discovery

See what CB Insights has to offer

Founded Year



Dead | Dead

Total Raised


About Vitra Bioscience

Vitra Bioscience, formerly Virtual Arrays, accelerates the discovery of new medicines by transforming critical rate-limiting steps in lead identification and optimization using its CellPlex(TM) technology that uniquely delivers multi-dimensional cellular information all at once, rather than sequentially when using current methods.

Vitra Bioscience Headquarter Location

2450 Bayshore Parkway

Mountain View, California, 94043,

United States


Latest Vitra Bioscience News

Vitra Bioscience Closes Doors as Investors Pull Out; Company Selling Cell-Assay Tech

Jan 6, 2017

Nov 28, 2005 Premium Vitra Bioscience, which commercially launched its flagship CellCard multiplexed cell-based assay system at the beginning of this year, has closed its doors and is currently seeking potential suitors to acquire all of the company's assets, according to two former Vitra officials. Ilya Ravkin, the company's co-founder and chief technology officer, told CBA News at IBC's High-Content Analysis conference held earlier this month in Washington, DC, that Vitra has "shut down" operations. Get the full story with GenomeWeb Premium Only $95 for the first 90 days* A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.